SEC 13F Intelligence

Investment Counsel Co Of Nevada / TYRA

Investment Counsel Co Of Nevada’s Tyra Biosciences Inc Position

Does Investment Counsel Co Of Nevada own Tyra Biosciences Inc (TYRA)? Not currently — the last reported position was 85.0K shares worth $2M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q4 2025
Shares
85.0K
% of Portfolio
+4.80%
Quarters Held
5
position exited

Position History TYRA

Reported value by quarter
Q4 ’24: $1MQ4 ’24Q1 ’25: $790,686Q1 ’25Q2 ’25: $813,642Q2 ’25Q3 ’25: $1MQ3 ’25Q4 ’25: $2MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 202585.0K$2M+4.80%
Q3 202585.0K$1M+2.42%
Q2 202585.0K$813,642+1.67%
Q1 202585.0K$790,686+1.80%
Q4 202485.0K$1M+3.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Investment Counsel Co Of Nevada’s full portfolio or all institutional holders of TYRA.